Journal of Clinical Sleep Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2024-09-21 ms9000000540037569 来自山西省

这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2024-01-28 ms3000001646022466 来自浙江省

请问这个期刊是OA吗，怎么还有50美金的submission fee

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2024-03-09 ms9000000168573392 来自甘肃省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。

63 0

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

讨论的字数一般控制在多少？

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？

114 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2021-11-29 JinnTsai

请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。

128 0

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2021-11-29 JinnTsai

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床睡眠
经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！

125 0

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2013-03-17 zhuiying323

审稿速度:1.0 | 投稿命中率:25.0
经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。

469 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2020-01-10 lovetcm

***ningding 2013-02-23 18:28:00 发表:
这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。

ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。

231 0

[GetPortalCommentsPageByObjectIdResponse(id=2226895, encodeId=333d222689549, content=这个杂志还接收纯生信的文章吗，感觉它这种文章收的比较少 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1af49470655, createdName=ms9000000540037569, createdTime=Sat Sep 21 13:48:28 CST 2024, time=2024-09-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2184471, encodeId=bac321844e10d, content=请问这个期刊是OA吗，怎么还有50美金的submission fee, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=753a5630277, createdName=ms3000001646022466, createdTime=Sun Jan 28 17:28:46 CST 2024, time=2024-01-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192203, encodeId=0dae2192203b5, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：23年10月26号投的，12月5号还是几号返修，我有点忙，2月1号才把返修传上去，今早被接受。我写的是OSA治疗的meta和系统评价，纳入了4篇，只有2篇用于meta。希望对你有帮助，祝早日见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=995d5706157, createdName=ms9000000168573392, createdTime=Sat Mar 09 08:58:01 CST 2024, time=2024-03-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1104407, encodeId=16b7110440e09, content=讨论的字数一般控制在多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104408, encodeId=0e9f1104408de, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075102, encodeId=783c10e5102fa, content=请问这个杂志有reviewers invited这个状态吗？已经with editor三周了。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:11:27 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075104, encodeId=d2d610e51044d, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床睡眠 经验分享：请问大家这个杂志有reviewers invited状态吗？已经with editor三周了。。。谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e825435772, createdName=JinnTsai, createdTime=Mon Nov 29 16:24:43 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494388, encodeId=a7a449438888, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：上篇经验里说到的我的那篇文章，已经被接收了。认真修改很重要。语言要求严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d85d65061, createdName=zhuiying323, createdTime=Sun Mar 17 09:17:00 CST 2013, time=2013-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583066, encodeId=ea1d583066ae, content=***ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, beContent=ningding 2013-02-23 18:28:00 发表: 这是美国睡眠学会旗下的第二个杂志，一个新办的刊物（第一个是睡眠领域老大：SLEEP）。靠山强，估计长期发展不会差。我的一篇文章已经二审修回。感觉还是比较友好，但是要求苛刻，如果给你修改的机会，一定要抓住；修改的不好会被果断枪毙。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504677, encodeId=4d1c5046e739, content=太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=doctor680, createdTime=Wed Jul 30 13:25:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]

2014-07-30 doctor680

太稳了吧，稍微加强点，不就突破3分了吗？真的好难好难

404 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务